SCHEMBL9610517

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9610510	0.91	ELANE (0.36)	ELANEALDH1A1MAPTNOTUM
	SCHEMBL2775873	0.84	ELANE (0.39)	ELANEKMT2AMEN1ALDH1A1MAPT
	SCHEMBL9610509	0.83	HSD17B3 (0.40)	ELANEALDH1A1LMNAHSD17B3KIF11
	SCHEMBL9610513	0.81	ELANE (0.37)	ELANEPKMKDM4EKIF11
	SCHEMBL9610487	0.81	ELANE (0.39)	ELANESMN1; SMN2MAPK1KMT2AMEN1
	SCHEMBL16775518	0.81	MAPK1 (0.35)	SMN1; SMN2MAPK1KMT2AMEN1LMNA
	SCHEMBL9610537	0.80	ELANE (0.36)	ELANESMN1; SMN2MAPK1KMT2AMEN1
	SCHEMBL9610614	0.79	ELANE (0.35)	ELANE
	SCHEMBL9610590	0.79	ELANE (0.35)	ELANEKMT2AMEN1
	SCHEMBL9610410	0.78	KDM1A (0.36)	SIGMAR1HDAC9TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.